The American Hospital Association says UnitedHealthcare's Specialty pharmacy coverage policies undermine the 340B program's intent. | Shutterstock

AHA Asks CMS to Rein In UHC’s Specialty Pharmacy Policies

The American Hospital Association (AHA) last week told the U.S. Centers for Medicare & Medicaid Services (CMS) that insurance company UnitedHealthcare’s (UHC) specialty pharmacy coverage policies “undermine the intent of the 340B program” and should be disallowed.

In a Feb. 4 letter, AHA told CMS that UHC “is upending the traditional system” in which hospitals buy, store, and administer specialty drugs and then bill payers for the cost and administration of such drugs. It said UHC health plans “are no longer permitting many providers (under penalty of non-payment) to acquire and store a variety of drugs needed to treat their patients.”

The American Hospital Association (AHA) last week told the U.S. Centers for Medicare & Medicaid Services (CMS) that insurance company UnitedHealthcare’s (UHC) specialty pharmacy coverage policies “undermine the intent of the 340B program” and should be disallowed.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report